Komori
Human Metabolome Technologies (6090) · FactFirst stated

Obtaining a marketing authorization license for in vitro diagnostic products

First written in FY2017. . Latest entry: FY2017.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Obtaining a marketing authorization license for in vitro diagnostic productsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2017First statedAnnual report

    「HMTバイオメディカル株式会社 obtained a license to manufacture and market in vitro diagnostic products.」

    The disclosure states that HMTバイオメディカル株式会社 obtained a license to manufacture and market in vitro diagnostic products.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.